Paclitaxel, ifosfamide, and nedaplatin (TIN) salvage chemotherapy for patients with advanced germ cell tumors
Author:
Publisher
Wiley
Subject
Urology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1442-2042.2006.01702.x/fullpdf
Reference21 articles.
1. Curing metastatic testicular cancer;Einhorn;Proc. Natl Acad. Sci. USA,2002
2. Testicular cancer: an oncological success story;Einhorn;Clin. Cancer Res.,1997
3. Cisplatin and ifosfamide with either vinblastine or etoposide as salvage therapy for refractory or relapsing germ cell tumor patients: the Institut Gustave Roussy experience;Farhat;Cancer,1996
4. Ifosfamide- and cisplatin-containing chemotherapy as first-line salvage therapy in germ cell tumors: response and survival;McCaffrey;J. Clin. Oncol.,1997
5. Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor;Loehrer;J. Clin. Oncol.,1998
Cited by 13 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Overcoming Chemotherapy Resistance in Germ Cell Tumors;Biomedicines;2022-04-22
2. Less nephrotoxicity of paclitaxel and ifosfamide plus nedaplatin for refractory or relapsed germ cell tumors in patients with impaired renal function;International Journal of Urology;2019-11-07
3. A case of mediastinal growing teratoma syndrome relapsing after resection by malignant transformation of sarcomatoid component;The Journal of the Japanese Association for Chest Surgery;2017
4. Metastatic testicular cancer presenting with liver and kidney dysfunction treated with modified BEP chemotherapy combined with continuous hemodiafiltration and rasburicase;Anti-Cancer Drugs;2016-04
5. Current chemotherapeutic approaches for recurrent or refractory germ cell tumors;Urologic Oncology: Seminars and Original Investigations;2015-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3